Alnylam Pharmaceuticals
ALNY
#536
Rank
HK$350.33 B
Marketcap
HK$2,652
Share price
0.44%
Change (1 day)
23.91%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company